Searle to launch a lifesaving drug for hospitalized COVID19 patients
Karachi, May 30, 2020: The Searle Company Limited has successfully entered into an exclusive licensing & marketing agreement with Beximco Pharmaceuticals, Bangladesh. Searle is the first and only pharmaceutical company in Pakistan to source the generic version of Remdesivir for the treatment of Covid-19 through the Patient Access Program. Remdesivir is a direct acting broad-spectrum…